ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 32 filers reported holding ASLAN PHARMACEUTICALS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,747,000 | -20.8% | 1,941,219 | -1.5% | 0.03% | 0.0% |
| Q4 2021 | $2,206,000 | -37.1% | 1,970,000 | 0.0% | 0.03% | -28.2% |
| Q3 2021 | $3,507,000 | -57.8% | 1,970,000 | -21.8% | 0.04% | -53.6% |
| Q2 2021 | $8,316,000 | -1.5% | 2,520,000 | 0.0% | 0.08% | +6.3% |
| Q1 2021 | $8,442,000 | – | 2,520,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 1,194,070 | $3,940,000 | 2.71% |
| Sio Capital Management, LLC | 1,488,508 | $4,912,000 | 1.22% |
| MANGROVE PARTNERS IM, LLC | 2,514,576 | $8,298,000 | 0.85% |
| KNOTT DAVID M | 478,186 | $1,578,000 | 0.56% |
| Logos Global Management LP | 2,000,000 | $6,600,000 | 0.56% |
| DAFNA Capital Management LLC | 677,500 | $2,236,000 | 0.47% |
| Vivo Capital, LLC | 2,840,909 | $9,375,000 | 0.41% |
| SABBY MANAGEMENT, LLC | 765,276 | $2,525,000 | 0.36% |
| MYDA Advisors LLC | 211,165 | $697,000 | 0.17% |
| Parkman Healthcare Partners LLC | 225,881 | $745,000 | 0.16% |